Coagulant Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Coagulant Therapeutics?

Coagulant Therapeutics is funded by IMM Investment.

Overview

Coagulant Therapeutics

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Coagulant Therapeutics

CB Rank

310894

Coagulant Therapeutics develops medical solutions to acute bleeding and blunt trauma.

Founded

obfuscation

Private

Venture - Series Unknown

San Francisco, California, United States

1-10

www.coagulanttherapeutics.com

Biopharma

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Terry Hermiston: CEO & Founder
Past Role: Schering AG, Scientific Director

Details

Legal Name

Coagulant Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Terry Hermiston

About the Company

Coagulant Therapeutics develops medical solutions to acute bleeding and blunt trauma. It researches on pharmaceutical advances to cure and prevent hemorrhaging. Coagulant Therapeutics is based in California, USA.

Phone Number

+1-855-573-5566

Contact Email

jjung@coagulanttherapeutics.com.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CT-001

A next-generation Factor VIIa designed for rapid clearance and enhanced hemostatic activity to treat acute bleeding, including severe postpartum hemorrhage.

APC Antibody Program

A research initiative to develop therapeutic antibodies targeting activated protein C (APC) for treating trauma, hemophilia, ischemia, and sepsis.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Coagulant Therapeutics	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
IMM Investment	—	Venture Round - Coagulant Therapeutics	—
IMM Investment	—	Venture Round - Coagulant Therapeutics	—
IMM Investment	—	Venture Round - Coagulant Therapeutics	—
IMM Investment	—	Venture Round - Coagulant Therapeutics	—
IMM Investment	—	Venture Round - Coagulant Therapeutics	—